Ultrasound-responsive nanobubbles contained with peptide–camptothecin conjugates for targeted drug delivery

References

• Aroui S, Brahim S, De Waard M, Kenani A. (2010). Cytotoxicity intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study. Biochem Biophys Res Commun 391:419–25
   PubMed Web of Science ®Google Scholar
• de Saint Victor M, Crake C, Coussios CC, Stride E. (2014). Properties, characteristics and applications of microbubbles for sonothrombolysis. Expert Opin Drug Deliv 11:187–209
   PubMed Web of Science ®Google Scholar
• Derossi D. (1998). Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol 8:84–7
   PubMed Web of Science ®Google Scholar
• Du L, Jin Y, Zhou W, Zhao J. (2011). Ultrasound-triggered drug release and enhanced anticancer effect of doxorubicin-loaded poly(D,L-lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanodroplets. Ultrasound Med Biol 37:1252–8
   PubMed Web of Science ®Google Scholar
• Escoffre JM, Mannaris C, Geers B, et al. (2013). Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery. IEEE Trans. Ultrason Ferroelectr Freq Control 60:78–87
   PubMed Web of Science ®Google Scholar
• Fischer PM, Zhelev NZ, Wang S, et al. (2000). Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin. J Pept Res 55:163–72
   PubMedGoogle Scholar
• Fonseca SB, Pereira MP, Kelley SO. (2009). Recent advances in the use of cellpenetrating peptides for medical and biological applications. Adv Drug Deliv Rev 61:953–64
   PubMed Web of Science ®Google Scholar
• Gao W, Xiang B, Meng TT, et al. (2013). Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. Biomaterials 34:4137–49
   PubMed Web of Science ®Google Scholar
• He X, Wu DF, Ji J, et al. (2015). Ultrasound microbubble-carried PNA targeting to c-myc mRNA inhibits the proliferation of rabbit iliac arterious smooth muscle cells and intimal hyperplasia. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2015.1014947
   Web of Science ®Google Scholar
• Henne WA, Doorneweerd DD, Hilgenbrink AR, et al. (2006). Synthesis and activity of a folate peptide camptothecin prodrug. Bioorg Med Chem Lett 16:5350–5
   PubMed Web of Science ®Google Scholar
• Lindgren M, Langel U. (2011). Classes and prediction of cell-penetrating peptides. Methods Mol Biol 683:3–19
   PubMedGoogle Scholar
• Lindgren M, Rosenthal-Aizman K, Saar K, et al. (2006). Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide. Biochem Pharmacol 71:416–25
   PubMed Web of Science ®Google Scholar
• Mahalingam S, Raimi-Abraham BT, Craig DQ, Edirisinghe M. (2015). Formation of protein and protein-gold nanoparticle stabilized microbubbles by pressurized gyration. Langmuir 31:659–66
   PubMed Web of Science ®Google Scholar
• Moon C, Kwon YM, Lee WK, et al. (2008). A novel polyrotaxane-based intracellular delivery system for camptothecin: in vitro feasibility evaluation. J Biomed Mate Res A 84:238–46
   PubMed Web of Science ®Google Scholar
• Parhizkar M, Stride E, Edirisinghe M. (2014). Preparation of monodisperse microbubbles using an integrated embedded capillary T-junction with electrohydrodynamic focusing. Lab Chip 14:2437–46
   PubMed Web of Science ®Google Scholar
• Pessah N, Reznik M, Shamis M, et al. (2004). Bioactivation of carbamate-based 20(S)-camptothecin prodrugs. Bioorg Med Chem 12:1859–66
   PubMed Web of Science ®Google Scholar
• Stride E. (2015). Physical principles of microbubbles for ultrasound imaging and therapy. Front Neurol Neurosci 36:11–22
   PubMedGoogle Scholar
• Taghizadeh B, Taranejoo S, Monemian SA, et al. (2015). Classification of stimuli-responsive polymers as anticancer drug delivery systems. Drug Deliv 22:145–55
   PubMed Web of Science ®Google Scholar
• Torchilin VP. (2000). Drug targeting. Eur J Pharm Sci 11:S81–91
   PubMed Web of Science ®Google Scholar
• Tsu-Yin W, Wilson KE, Machtaler S, Willmann JK. (2013). Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical application. Curr Pharm Biotechnol 14:743–52
   PubMed Web of Science ®Google Scholar
• Vivès E. (2005). Present and future of cell-penetrating peptide mediated delivery systems: “is the Trojan horse too wild to go only to Troy?” J Control Release 109:77–85
   PubMed Web of Science ®Google Scholar
• Xiang B, Dong DW, Shi NQ, et al. (2013). PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer. Biomaterials 34:6976–91
   PubMed Web of Science ®Google Scholar
• Xie X, Yang Y, Yang Y, et al. (2015). A photo-responsive peptide- and asparagine–glycine–arginine (NGR) peptide-mediated liposomal delivery system. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.2015.1008707
   Web of Science ®Google Scholar
• Yang Y, Yang YF, Xie XY, et al. (2014). Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier. J Drug Target 22:891–900
   PubMed Web of Science ®Google Scholar
• Zhang JA, Anyarambhatla G, Ma L, et al. (2005). Development and characterization of a novel Cremophorw EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 59:177–87
   PubMed Web of Science ®Google Scholar
• Zhang W, Song J, Zhang B, et al. (2011). Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells. Bioconjugate Chem 22:1410–15
   PubMed Web of Science ®Google Scholar
• Zhou ZY, Zhang P, Ren JL, et al. (2013). Synergistic effects of ultrasound-targeted microbubble destruction and TAT peptide on gene transfection: an experimental study in vitro and in vivo. J Control Rel 170:437–44
   PubMed Web of Science ®Google Scholar
• Zhu F, Jiang Y, Luo F, Li P. (2015). Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model. J Drug Target 23:323–34
   PubMed Web of Science ®Google Scholar
• Zorko M ÜL. (2005). Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev 57:529–45
   PubMed Web of Science ®Google Scholar